[
  {
    "masterId": "NCLEX-2026-MISSION-500-22-1771960134229",
    "itemType": "standalone",
    "topic": "Preeclampsia/Eclampsia (HELLP)",
    "category": "audioVideo",
    "difficulty": 5,
    "stem": "A 28-year-old primigravida, G1P0 at 34 weeks gestation, is admitted to the labor and delivery unit. Review the EHR and address the tasks.",
    "itemContext": {
      "SBAR": "**Situation:**\nMrs. Emily Carter, a 28-year-old primigravida at 34 weeks gestation, was admitted at 14:00 today for preeclampsia. She reports a severe headache, blurred vision, and epigastric pain. \n\n**Background:**\nShe has a history of well-controlled hypertension prior to pregnancy. Her blood pressure has been elevated over the past two weeks, with proteinuria confirmed at her last prenatal visit. No known allergies. Vital signs stable upon admission, but reports increasing discomfort. \n\n**Assessment:**\nAlert and oriented x3. BP 160/110 mmHg, HR 92 bpm, RR 20, SpO2 98% on room air, Temp 37.1째C (98.8째F). 3+ protein in urine. Deep tendon reflexes 3+ with 2 beats of ankle clonus bilaterally. Complaining of severe headache and epigastric pain. Assessment reveals possible HELLP syndrome.\n\n**Recommendation:**\nI recommend stat labs (CBC, CMP, LDH, AST, ALT, uric acid), continuous fetal monitoring, and Magnesium Sulfate IV bolus followed by a maintenance dose. Prepare for possible delivery based on lab results and patient condition. Strict I&O monitoring is essential.",
      "Labs": "Hemoglobin: 9.8 g/dL, Platelets: 90,000/mcL, AST: 250 U/L, ALT: 300 U/L, LDH: 700 U/L, Creatinine: 1.4 mg/dL, Uric Acid: 7.0 mg/dL",
      "Vitals": "14:00: BP 160/110 mmHg, HR 92 bpm, RR 20, SpO2 98% RA, Temp 37.1째C (98.8째F)",
      "Radiology": "N/A",
      "MAR": "Magnesium Sulfate 4g IV bolus over 20 minutes (prescribed), Magnesium Sulfate 2g/hr continuous infusion (prescribed), Labetalol 20mg IV PRN for SBP >160 mmHg (prescribed)"
    },
    "tasks": [
      {
        "taskId": "task1",
        "taskType": "matrix",
        "stem": "For each potential intervention, indicate if it is indicated, contraindicated, or non-essential for the client at this time.",
        "options": [
          "Administer Labetalol 20mg IV PRN for SBP >160 mmHg",
          "Prepare for immediate cesarean section",
          "Administer Methylergonovine IM",
          "Monitor urine output hourly",
          "Administer Furosemide IV"
        ],
        "responseOptions": [
          "Indicated",
          "Contraindicated",
          "Non-Essential"
        ],
        "correctResponse": [
          "Indicated",
          "Indicated",
          "Contraindicated",
          "Indicated",
          "Contraindicated"
        ],
        "rationale": {
          "Administer Labetalol 20mg IV PRN for SBP >160 mmHg": "Labetalol is an antihypertensive agent used to manage severe hypertension associated with preeclampsia/eclampsia. Given the client's BP of 160/110 mmHg, this intervention is indicated to prevent further complications such as stroke.",
          "Prepare for immediate cesarean section": "Given the HELLP syndrome indicators (thrombocytopenia, elevated liver enzymes), gestational age (34 weeks), and uncontrolled blood pressure, immediate delivery is often the most appropriate intervention to prevent maternal and fetal morbidity and mortality. Cesarean section may be necessary depending on maternal and fetal status.",
          "Administer Methylergonovine IM": "Methylergonovine is a uterotonic agent used to manage postpartum hemorrhage. It is contraindicated in patients with hypertension as it can further elevate blood pressure. In the context of preeclampsia/eclampsia with elevated BP, it is absolutely contraindicated.",
          "Monitor urine output hourly": "Monitoring urine output hourly is crucial to assess renal perfusion and detect oliguria, which can be a sign of worsening preeclampsia or acute kidney injury. This intervention helps in managing fluid balance and preventing complications.",
          "Administer Furosemide IV": "Furosemide, a loop diuretic, is generally contraindicated in preeclampsia unless there is evidence of pulmonary edema or heart failure. Diuretics can further reduce intravascular volume and worsen placental perfusion in preeclamptic patients. It is not indicated in this scenario."
        }
      },
      {
        "taskId": "task2",
        "taskType": "highlight",
        "stem": "Highlight the findings in the 'Labs' report that support a diagnosis of HELLP syndrome.",
        "text": "Hemoglobin: 9.8 g/dL, Platelets: 90,000/mcL, AST: 250 U/L, ALT: 300 U/L, LDH: 700 U/L, Creatinine: 1.4 mg/dL, Uric Acid: 7.0 mg/dL",
        "correctResponse": [
          "Hemoglobin: 9.8 g/dL",
          "Platelets: 90,000/mcL",
          "AST: 250 U/L",
          "ALT: 300 U/L",
          "LDH: 700 U/L"
        ],
        "rationale": {
          "Hemoglobin: 9.8 g/dL": "Low hemoglobin suggests hemolysis, a component of HELLP syndrome (Hemolysis, Elevated Liver enzymes, and Low Platelets).",
          "Platelets: 90,000/mcL": "Thrombocytopenia (low platelet count) is a key diagnostic criterion for HELLP syndrome.",
          "AST: 250 U/L": "Elevated AST (Aspartate Aminotransferase) indicates liver damage, consistent with HELLP syndrome.",
          "ALT: 300 U/L": "Elevated ALT (Alanine Aminotransferase) indicates liver damage, consistent with HELLP syndrome.",
          "LDH: 700 U/L": "Elevated LDH (Lactate Dehydrogenase) indicates tissue damage, often associated with hemolysis in HELLP syndrome.",
          "Creatinine: 1.4 mg/dL": "Creatinine may be elevated in preeclampsia due to reduced kidney function. While not directly part of HELLP, it reflects end-organ damage.",
          "Uric Acid: 7.0 mg/dL": "Elevated uric acid is associated with preeclampsia, reflecting decreased renal perfusion and increased purine metabolism. While suggestive, it is not a primary diagnostic marker for HELLP syndrome itself."
        }
      },
      {
        "taskId": "task3",
        "taskType": "bowtie",
        "stem": "The client is exhibiting signs and symptoms of HELLP syndrome. Indicate the sequence of actions the nurse should take.",
        "options": [
          "Administer Magnesium Sulfate IV bolus.",
          "Monitor fetal heart rate patterns.",
          "Notify the healthcare provider immediately.",
          "Draw stat lab samples (CBC, CMP, LDH, AST, ALT, uric acid).",
          "Prepare for possible delivery.",
          "Assess deep tendon reflexes and clonus."
        ],
        "linked dyads/triads": [
          [
            "Notify the healthcare provider immediately.",
            "Draw stat lab samples (CBC, CMP, LDH, AST, ALT, uric acid).",
            "Assess deep tendon reflexes and clonus."
          ],
          [
            "Administer Magnesium Sulfate IV bolus.",
            "Prepare for possible delivery.",
            "Monitor fetal heart rate patterns."
          ]
        ],
        "correctResponse": [
          "Notify the healthcare provider immediately.",
          "Draw stat lab samples (CBC, CMP, LDH, AST, ALT, uric acid).",
          "Assess deep tendon reflexes and clonus.",
          "Administer Magnesium Sulfate IV bolus.",
          "Prepare for possible delivery.",
          "Monitor fetal heart rate patterns."
        ],
        "rationale": {
          "Notify the healthcare provider immediately.": "The initial action is to notify the healthcare provider of the patient's condition and the suspicion of HELLP syndrome to facilitate prompt medical intervention.",
          "Draw stat lab samples (CBC, CMP, LDH, AST, ALT, uric acid).": "Drawing stat lab samples is crucial to confirm the diagnosis of HELLP syndrome and assess the severity of the condition.",
          "Assess deep tendon reflexes and clonus.": "Assessing deep tendon reflexes and clonus is important to evaluate the central nervous system irritability and the risk of seizures due to preeclampsia.",
          "Administer Magnesium Sulfate IV bolus.": "Magnesium sulfate is administered to prevent seizures, a common complication of severe preeclampsia and eclampsia. It is essential to protect the mother from neurological complications.",
          "Prepare for possible delivery.": "Given the gestational age and the severity of HELLP syndrome, preparing for possible delivery is essential to prevent further maternal and fetal complications. Delivery is often the definitive treatment for HELLP syndrome.",
          "Monitor fetal heart rate patterns.": "Continuous fetal monitoring is crucial to assess fetal well-being and detect signs of fetal distress, which may necessitate expedited delivery."
        }
      }
    ],
    "clinicalPearls": [
      "HELLP syndrome is a severe complication of preeclampsia characterized by Hemolysis, Elevated Liver enzymes, and Low Platelets. Prompt recognition and intervention are critical to prevent maternal and fetal morbidity and mortality.",
      "Magnesium sulfate is the drug of choice for seizure prophylaxis in preeclampsia/eclampsia. Monitor for signs of magnesium toxicity (decreased reflexes, respiratory depression, altered mental status).",
      "Delivery is often the definitive treatment for HELLP syndrome. The decision regarding the mode and timing of delivery depends on gestational age, maternal condition, and fetal status.",
      "Labetalol and hydralazine are commonly used antihypertensive agents in preeclampsia. Avoid ACE inhibitors and ARBs during pregnancy due to teratogenic effects.",
      "Strict intake and output monitoring is essential to assess renal function and prevent fluid overload or dehydration."
    ],
    "questionTrap": "Many students may overlook the contraindications for Methylergonovine in hypertensive patients. They might also fail to recognize all of the lab values indicating HELLP syndrome or the importance of preparing for delivery in this scenario.",
    "mnemonic": "HELLP: Hemolysis, Elevated Liver enzymes, Low Platelets",
    "references": [
      "American College of Obstetricians and Gynecologists (ACOG). (2020). Hypertension in Pregnancy. Task Force on Hypertension in Pregnancy.",
      "Sibai, B. M. (2012). Management of HELLP syndrome. Clinical Obstetrics and Gynecology, 55(1), 131-144."
    ],
    "audioVideo": null,
    "type": "standalone",
    "scoring": {
      "method": "polytomous",
      "maxPoints": 1
    }
  }
]